Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Bruno

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Haematologica|August 30, 2008
Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO)Francesca Patriarca, Andrea Bacigalupo, Alessandra Sperotto, et al.
Heliyon|December 5, 2022
The effect of gamified robot-enhanced training on motor performance in chronic stroke survivorsArzu Guneysu Ozgur, Maximilian J Wessel, Jennifer K Olsen, et al.
Blood|February 2, 2006
Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day +5 responders and no advantage for nonresponders receiving anti-thymocyte globulinMaria Teresa Van Lint, Giuseppe Milone, Salvatore Leotta, et al.
Metabolites|February 25, 2023
Salivary Metabolomic Analysis Reveals Amino Acid Metabolism Shift in SARS-CoV-2 Virus Activity and Post-Infection ConditionTatiana Kelly da Silva Fidalgo, Liana Bastos Freitas-Fernandes, Barbara Bruno Fagundes Marques, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 19, 2010
Rituximab treatment for Epstein-Barr virus DNAemia after alternative-donor hematopoietic stem cell transplantationStefania Coppoletta, Elisabetta Tedone, Barbara Galano, et al.
Blood|June 12, 2009
Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantationRoberto Crocchiolo, Elisabetta Zino, Luca Vago, et al.
Haematologica|July 5, 2006
Boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantationAlessandra Larocca, Giovanna Piaggio, Marina Podestà, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 24, 2018
Busulfan- or Thiotepa-Based Conditioning in Myelofibrosis: A Phase II Multicenter Randomized Study from the GITMO GroupFrancesca Patriarca, Arianna Masciulli, Andrea Bacigalupo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 31, 2013
Adjuvant high-dose chemotherapy with autologous hematopoietic stem cell support for high-risk primary breast cancer: results from the Italian national registryPaolo Pedrazzoli, Giovanni Martinelli, Alessandro Massimo Gianni, et al.
Haematologica|October 13, 2004
Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantationAndrea Bacigalupo, Maria Pia Sormani, Teresa Lamparelli, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Haematologica|August 30, 2008
Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO)Francesca Patriarca, Andrea Bacigalupo, Alessandra Sperotto, et al.
Heliyon|December 5, 2022
The effect of gamified robot-enhanced training on motor performance in chronic stroke survivorsArzu Guneysu Ozgur, Maximilian J Wessel, Jennifer K Olsen, et al.
Blood|February 2, 2006
Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day +5 responders and no advantage for nonresponders receiving anti-thymocyte globulinMaria Teresa Van Lint, Giuseppe Milone, Salvatore Leotta, et al.
Metabolites|February 25, 2023
Salivary Metabolomic Analysis Reveals Amino Acid Metabolism Shift in SARS-CoV-2 Virus Activity and Post-Infection ConditionTatiana Kelly da Silva Fidalgo, Liana Bastos Freitas-Fernandes, Barbara Bruno Fagundes Marques, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 19, 2010
Rituximab treatment for Epstein-Barr virus DNAemia after alternative-donor hematopoietic stem cell transplantationStefania Coppoletta, Elisabetta Tedone, Barbara Galano, et al.
Blood|June 12, 2009
Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantationRoberto Crocchiolo, Elisabetta Zino, Luca Vago, et al.
Haematologica|July 5, 2006
Boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantationAlessandra Larocca, Giovanna Piaggio, Marina Podestà, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 24, 2018
Busulfan- or Thiotepa-Based Conditioning in Myelofibrosis: A Phase II Multicenter Randomized Study from the GITMO GroupFrancesca Patriarca, Arianna Masciulli, Andrea Bacigalupo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 31, 2013
Adjuvant high-dose chemotherapy with autologous hematopoietic stem cell support for high-risk primary breast cancer: results from the Italian national registryPaolo Pedrazzoli, Giovanni Martinelli, Alessandro Massimo Gianni, et al.
Haematologica|October 13, 2004
Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantationAndrea Bacigalupo, Maria Pia Sormani, Teresa Lamparelli, et al.
Pageof 6